Current Progress in Keloid Research and Treatment

Journal of the American College of Surgeons

Volumn 206, Issue 4, 2008, Pages 731-741

  Butler, Paris D ^a,b   Longaker, Michael T ^a   Yang, George P ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BLEOMYCIN; COBALT 60; DNA; FLUOROURACIL; GROWTH FACTOR; IMIQUIMOD; INTERLEUKIN 10; SCLEROPROTEIN; STEROID; TRANSFORMING GROWTH FACTOR BETA3; TRIAMCINOLONE; VERAPAMIL;

APOPTOSIS; COBALT THERAPY; COMPRESSION THERAPY; CRYOSURGERY; DRUG EFFICACY; DRUG FORMULATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; HYPOPIGMENTATION; INJECTION SITE PAIN; KELOID; LOW LEVEL LASER THERAPY; MESENCHYME; MONOTHERAPY; NONHUMAN; PAIN; PLASTIC SURGERY; PRIORITY JOURNAL; PRURITUS; REVIEW; SCAR FORMATION; SCAR ULCERATION; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN ATROPHY; SKIN EXFOLIATION; SKIN INJURY; SKIN IRRITATION; SKIN PIGMENTATION; TATTOOING; TELANGIECTASIA; WOUND HEALING;

HUMANS; KELOID; RESEARCH; WOUND HEALING;

EID: 41149090611     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.12.001     Document Type: Review

References (93)

1. Russell S.B., Trupin K.M., Rodriguez-Eaton S., et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci U S A 85 (1988) 587-591
2. Atiyeh B.S., Costagliola M., and Hayek S.N. Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg 54 (2005) 676-680
3. Nirodi C.S., Devalaraja R., Nanney L.B., et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen 8 (2000) 371-382
4. Marneros A.G., Norris J.E., Watanabe S., et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 122 (2004) 1126-1132
5. Bayat A., Bock O., Mrowietz U., et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstruct Surg 111 (2003) 535-543 discussion 544
6. Tuan T.L., and Nichter L.S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4 (1998) 19-24
7. Rekha A. Keloids-a frustrating hurdle in wound healing. Int Wound J 1 (2004) 145-148
8. De Felice B., Wilson R.R., Nacca M., et al. Molecular characterization and expression of p63 isoforms in human keloids. Mol Genet Genomics 272 (2004) 28-34
9. Alibert J.L.M. Note sur la keloide. J Univ Sci Med 2 (1816) 207-216
10. Mustoe T.A., Cooter R.D., Gold M.H., et al. International clinical recommendations on scar management. Plast Reconstr Surg 110 (2002) 560-571
11. Tanaka A., Hatoko M., Tada H., et al. S. Expression of p53 family in scars. J Dermatol Sci 34 (2004) 17-24
12. Amadeu T., Braune A., Mandarim-de-Lacerda C., et al. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract 199 (2003) 469-473
13. Meenakshi J.V., Ramakrishnan K.M., and Babu M. Keloids and hypertrophic scars: a review. Indian J Plast Surg 38 (2005) 175-179
14. Ehrlich H.P., Desmouliere A., Diegelmann R.F., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145 (1994) 105-113
15. Boyadjiev C., Popchristova E., and Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma 38 (1995) 299-302
16. Kischer C.W., and Shetlar M.R. Collagen and mucopolysaccharides in the hypertrophic scar. Connect Tissue Res 2 (1974) 205-213
17. Lee J.Y., Yang C.C., Chao S.C., and Wong T.W. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 26 (2004) 379-384
18. Sandulache V.C., Parekh A., Li-Korotky H., et al. Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis. Wound Repair Regen 15 (2007) 122-133
19. Xia W., Longaker M.T., and Yang G.P. P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts. Am J Physiol Regul Integr Comp Physiol 290 (2006) R501-R508
20. Chin G.S., Liu W., Peled Z., et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108 (2001) 423-429
21. Haisa M., Okochi H., and Grotendorst G.R. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 103 (1994) 560-563
22. Xia X.K.W., Phan T.T., Lim I.J., et al. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and Smad binding sites. Ann Surg 246 (2007) 886-895
23. Colwell A.S., Yun R., Krummel T.M., et al. Keratinocytes modulate fetal and postnatal fibroblast transforming growth factor-beta and Smad expression in co-culture. Plast Reconstr Surg 119 (2007) 1440-1445
24. Hsu M., Peled Z.M., Chin G.S., et al. Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin. Plast Reconstr Surg 107 (2001) 1787-1794 discussion 1795-1786
25. Soo C., Beanes S.R., Hu F.Y., et al. Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization. Am J Pathol 163 (2003) 2459-2476
26. Dang C.M., Beanes S.R., Soo C., et al. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg 111 (2003) 1969-1979
27. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 296 5573 (2002) 1646-1647
28. Igarashi A., Nashiro K., Kikuchi K., et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106 (1996) 729-733
29. Takigawa M.K., and Satoshi. CCN2. UCSD-Nature Molecule Pages (2007) (doi:10.1038/mp.a000001.01). Available at: http://www.signaling-gateway.org/molecule/query;jsessionid=c6ca4bf1229ce19e5aae2cbb41c09ecde6677f84322f?afcsid=A003961. Accessed January 23, 2008
30. Khoo Y.T., Ong C.T., Mukhopadhyay A., et al. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 208 (2006) 336-343
31. Ross R., Glomset J., Kariya B., and Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71 (1974) 1207-1210
32. Kohler N., and Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87 (1974) 297-301
33. Grotendorst G.R., Chang T., Seppa H.E., et al. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol 113 (1982) 261-266
34. Grotendorst G.R., Seppa H.E., Kleinman H.K., and Martin G.R. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A 78 (1981) 3669-3672
35. Bauer E.A., Cooper T.W., Huang J.S., et al. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A 82 (1985) 4132-4136
36. Blatti S.P., Foster D.N., Ranganathan G., et al. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci U S A 85 (1988) 1119-1123
37. Heldin P., Laurent T.C., and Heldin C.H. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 258 (1989) 919-922
38. Yoshimoto H., Ishihara H., Ohtsuru A., et al. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154 (1999) 883-889
39. Wu Y., Zhang Q., Ann D.K., et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 286 (2004) C905-C912
40. Tan E.M., and Peltonen J. Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts. Biochem J 278 (1991) 863-869
41. Zhang Q., Wu Y., Ann D.K., et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121 (2003) 1005-1012
42. Wang Z., Fong K.D., Phan T.T., et al. Increased transcriptional response to mechanical strain in keloid fibroblasts due to increased focal adhesion complex formation. J Cell Physiol 206 (2006) 510-517
43. Ramakrishnan K.M., Thomas K.P., and Sundararajan C.R. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 53 (1974) 276-280
44. Alenghat F.J., and Ingber D.E. Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE 2002 (2002) PE6
45. Shyy J.Y., and Chien S. Role of integrins in endothelial mechanosensing of shear stress. Circ Res 91 (2002) 769-775
46. Bershadsky A.D., Balaban N.Q., and Geiger B. Adhesion-dependent cell mechanosensitivity. Ann Rev Cell Dev Biol 19 (2003) 677-695
47. Chen B.P., Li Y.S., Zhao Y., et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 7 (2001) 55-63
48. Chiquet M. Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol 18 (1999) 417-426
49. Lin K., Hsu P.P., Chen B.P., et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A 97 (2000) 9385-9389
50. Meyer C.J., Alenghat F.J., Rim P., et al. Mechanical control of cyclic AMP signalling and gene transcription through integrins. Nat Cell Biol 2 (2000) 666-668
51. Meenakshi J.V., Ramakrishnan K.M., and Babu M. Ultrastructural differentiation of abnormal scars. Ann Burns Fire Disasters 18 (2005) 83
52. Ueberham A.U., Albrecht M., Herrmann K., and Haustein U. Spontaneous keloid is characterized by disturbed regulation of TGF-b1 expression and the collagen/collagenase balance. Eur J Dermatol 7 (1997) 333-338
53. Ghahary A., Shen Y.J., Nedelec B., et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106 (1996) 476-481
54. Ladin D.A., Hou Z., Patel D., et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 6 (1998) 28-37
55. Saed G.M., Ladin D., Olson J., et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 134 (1998) 963-967
56. Lim I.J., Phan T.T., Song C., et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 107 (2001) 797-808
57. Fusenig N. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: Leigh I., and Watt F. (Eds). The keratinocyte handbook (1994), Cambridge University Press, Cambridge 71-94
58. Mackenzie I. Epithelial-mesenchymal interactions in the development and maintenance of epithelial tissues. In: Leigh I., and Watt F. (Eds). The keratinocyte handbook (1994), Cambridge University Press, Cambridge 234-257
59. Maas-Szabowski N., Shimotoyodome A., and Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 112 (1999) 1843-1853
60. Boyce S. Epidermis as a secretory tissue. J Invest Dermatol 102 (1994) 8-10
61. Katz A.B., and Taichman L.B. Epidermis as a secretory tissue: an in vitro tissue model to study keratinocyte secretion. J Invest Dermatol 102 (1994) 55-60
62. Xia W., Phan T.T., Lim I.J., et al. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 12 (2004) 546-556
63. Xia W., Phan T.T., Lim I.J., et al. Differential transcriptional responses of keloid and normal keratinocytes to serum stimulation. J Surg Res 135 (2006) 156-163
64. Lu F., Gao J., Ogawa R., Hyakusoku H., and Ou C. Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues. Plast Reconstr Surg 120 (2007) 625-630
65. Wong T.W., Chiu H.C., Chang C.H., Lin L.J., Liu C.C., and Chen J.S. Silicone cream occlusive dressing-a novel noninvasive regimen in the treatment of keloid. Dermatology 192 (1996) 329-333
66. Bieley H.C., and Berman B. Effects of a water-impermeable, non-silicone-based occlusive dressing on keloids. J Am Acad Dermatol 35 (1996) 113-114
67. Robertson J.C., Hodgson B., Druett J.E., and Druett J. Pressure therapy for hypertrophic scarring: preliminary communication. J R Soc Med 73 (1980) 348-354
68. Estes F. Therapeutic options for patients with keloid scars. US Pharmacist 32 (2007) HS15-HS28
69. Niessen F.B., Spauwen P.H., Schalkwijk J., and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 (1999) 1435-1458
70. Slemp A.E., and Kirschner R.E. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18 (2006) 396-402
71. Berman B., and Bieley H.C. Adjunct therapies to surgical management of keloids. Dermatol Surg 22 (1996) 126-130
72. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg 11 (1977) 169-172
73. Davison S.P., Mess S., Kauffman L.C., and Al-Attar A. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg 117 (2006) 247-252
74. Jackson I., Bhageshpur R., DiNick V., et al. Investigation of recurrence rates among earlobe keloids utilizing various postoperative therapeutic modalities. Eur J Plast Surg 24 (2001) 88-95
75. Sallstrom K.O., Larson O., Heden P., et al. Treatment of keloids with surgical excision and postoperative x-ray radiation. Scand J Plast Reconstr Surg Hand Surg 23 (1989) 211-215
76. Kovalic J.J., and Perez C.A. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 17 (1989) 77-80
77. Escarmant P., Zimmermann S., Amar A., et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 26 (1993) 245-251
78. Ragoowansi R., Cornes P.G., Moss A.L., and Glees J.P. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg 111 (2003) 1853-1859
79. Meythiaz A., de Mey A., and Lejour M. Treatment of keloids by excision and postoperative radiotherapy. Eur J Plast Surg 15 (1992) 13-16
80. Malaker K., Zaidi M., and Franka M.R. Treatment of earlobe keloids using the cobalt 60 teletherapy unit. Ann Plast Surg 52 (2004) 602-604
81. Guix B., Henriquez I., Andres A., et al. Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys 50 (2001) 167-172
82. Norris J.E. Superficial x-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconstr Surg 95 (1995) 1051-1055
83. Hulsbergen Henning J.P., Roskam Y., and van Gemert M.J. Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med 6 (1986) 72-75
84. Norris J.E. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 87 (1991) 44-49 discussion 50-43
85. Paquet P., Hermanns J.F., and Pierard G.E. Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 27 (2001) 171-174
86. Rusciani L., Rossi G., and Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 19 (1993) 529-534
87. Farahnaz F., Jamshid N., and Koroush A. Comparison of therapeutic response of keloids and hypertrophic scars to cryotherapy plus intralesional steroid and bleomycin tattoo. Indian J Dermatol 50 (2005) 129-132
88. Gupta S., and Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 204 (2002) 130-132
89. Espana A., Solano T., and Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 27 (2001) 23-27
90. D'Andrea F., Brongo S., Ferraro G., and Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology 204 (2002) 60-62
91. Martin-Garcia R.F., and Busquets A.C. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg 31 (2005) 1394-1398
92. Stashower M.E. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg 32 (2006) 380-386
93. Connell P.G., and Harland C.C. Treatment of keloid scars with pulsed dye laser and intralesional steroid. J Cutan Laser Ther 2 (2000) 147-150